These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 21958174)
1. Autoimmune basis of glaucoma. Shazly TA; Aljajeh M; Latina MA Semin Ophthalmol; 2011; 26(4-5):278-81. PubMed ID: 21958174 [TBL] [Abstract][Full Text] [Related]
2. The case for autoimmunity in glaucoma. Wax MB Exp Eye Res; 2011 Aug; 93(2):187-90. PubMed ID: 20801114 [TBL] [Abstract][Full Text] [Related]
3. [Role of immune system in glaucomatous optic nerve degeneration]. Zhang Y; Zhao JL Zhonghua Yan Ke Za Zhi; 2007 Sep; 43(9):858-61. PubMed ID: 18070540 [TBL] [Abstract][Full Text] [Related]
4. The pathogenesis of glaucoma in the interplay with the immune system. Rieck J Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2393-409. PubMed ID: 23539162 [TBL] [Abstract][Full Text] [Related]
5. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation. Schwartz M; London A Prog Brain Res; 2008; 173():375-84. PubMed ID: 18929122 [TBL] [Abstract][Full Text] [Related]
6. What changes can we expect in the brain of glaucoma patients? Gupta N; YĆ¼cel YH Surv Ophthalmol; 2007 Nov; 52 Suppl 2():S122-6. PubMed ID: 17998036 [TBL] [Abstract][Full Text] [Related]
7. Immunoregulation of retinal ganglion cell fate in glaucoma. Wax MB; Tezel G Exp Eye Res; 2009 Apr; 88(4):825-30. PubMed ID: 19233171 [TBL] [Abstract][Full Text] [Related]
8. Disease progression and the need for neuroprotection in glaucoma management. Varma R; Peeples P; Walt JG; Bramley TJ Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotection in glaucoma - Is there a future role? Baltmr A; Duggan J; Nizari S; Salt TE; Cordeiro MF Exp Eye Res; 2010 Nov; 91(5):554-66. PubMed ID: 20800593 [TBL] [Abstract][Full Text] [Related]
11. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599 [TBL] [Abstract][Full Text] [Related]
12. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I]. Rokicki W; Dorecka M; Romaniuk W Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296 [TBL] [Abstract][Full Text] [Related]
13. Resistance of retinal ganglion cells to an increase in intraocular pressure is immune-dependent. Bakalash S; Kipnis J; Yoles E; Schwartz M Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2648-53. PubMed ID: 12147598 [TBL] [Abstract][Full Text] [Related]
14. Is there a role for the immune system in glaucomatous optic neuropathy? Wax MB Curr Opin Ophthalmol; 2000 Apr; 11(2):145-50. PubMed ID: 10848222 [TBL] [Abstract][Full Text] [Related]
15. Heat shock proteins, immunity and glaucoma. Tezel G; Yang J; Wax MB Brain Res Bull; 2004 Feb; 62(6):473-80. PubMed ID: 15036560 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies. Lee S; Van Bergen NJ; Kong GY; Chrysostomou V; Waugh HS; O'Neill EC; Crowston JG; Trounce IA Exp Eye Res; 2011 Aug; 93(2):204-12. PubMed ID: 20691180 [TBL] [Abstract][Full Text] [Related]
18. The role of glia, mitochondria, and the immune system in glaucoma. Tezel G; Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1001-12. PubMed ID: 19244206 [No Abstract] [Full Text] [Related]